The pro-angiogenic activity of the S1P–S1PR signaling axis, which contributes to tumor progression, including in osteosarcoma, offers a novel therapeutic avenue for targeting tumor-associated angiogenesis (88, 89). Here, MBTPS1 is linked to neoplasm.